Skip to main content

Median Effective Dose (ED50) of Esketamine Combined With Alfentanil for Children to Inhibit Body Movement During Laser Treatment for Facial Lesion

There is limited research on the combined use of esketamine and alfentanil for anesthesia during facial laser treatment in pediatric patients, and the effective dosage of esketamine for inhibiting body movement remains unclear. We explore the effective dose of esketamine combined with alfentanil for the inhibition of body movement during facial laser treatment in pediatric patients.

Status
unknown
Institution
Air Force Military Medical University, China
Start date
2024-03-27
End date
2025-04-27
Registry ID
NCT06294639

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.